Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-Obese Men With Metabolic Syndrome.

Trial Profile

Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-Obese Men With Metabolic Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2012

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Sep 2010 Planned end date changed from 1 Dec 2008 to 1 Oct 2010 as reported by ClinicalTrials.gov.
    • 30 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top